Use of SPIO-enhanced T1- and T2-weighted Images for the Differentiation of Liver Lesions: An ROC Analysis;Differenzierung von Leberläsionen mit SPIO-gestützten T 1-w und T2-w MRT-Aufnahmen: Eine ROC-Analyse

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 175, Issue 10, 2003, Pages 1368-1375

  Stroszczynski, Christian ^a   Gaffke, G ^a   Gretschel, S ^a   Rambow, A ^a   Jost, D ^a   Schlecht, I ^a   Schneider, U ^a   Schicke, B ^b   Hohenberger, P ^a   Gebauer, B ^a   Felix, R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Stat/Info: Tumorztr Berlin Buch   (Germany)

Author keywords

Iron oxides; Liver imaging; Liver specific contrast media; Magnetic resonance imaging

Indexed keywords

GADOLINIUM PENTETATE; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CYST; LIVER DISEASE; LIVER HEMANGIOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM;

ADULT; AGED; BIOPSY; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOCAL NODULAR HYPERPLASIA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; LAPAROSCOPY; LIVER; LIVER DISEASES; LIVER NEOPLASMS; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; OXIDES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0242268619     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42887     Document Type: Article

References (24)

1. Grimm J, Müller-Hülsbeck S, Blume J, Biederer J, Heller M. Vergleich von Doppel-Spiral-CT und MnDPDP-verstärkter MRT zur Erfassung und Charakterisierung von Leberläsionen. Fortschr Röntgenstr 2001; 173: 266-272
2. Helmberger T, Gregor M, Holzknecht N, Rau H, Scheidler J, Reiser M. Einfluss von biphasischer Spiral-CT, nativer und eisenoxidverstärkter MRT auf Therapie und Therapiekosten bei Patienten mit fokalen Leberläsionen. Fortschr Röntgenstr 2000; 172: 251-259
3. Kreft B, Pauleit D, Bachmann R,Conrad R, Krämer A, Schild HH. Häufigkeit und Bedeutung von kleinen fokalen Leberläsionen in der MRT. Fortschr Röntgenstr 2001; 173: 424-429
4. Vogl TJ, Eichler K, Zangos S, Mack M, Hammerstingl R. Das hepatozelluläre Karzinom. Rolle der Bildgebung zur Detektion, Therapieplanung und Therapiekontrolle. Fortschr Röntgenstr 2002; 174: 1358-1368
5. Hirohashi S, Ueda K, Uchida H, Ono W, Takahama J, Takewa M, Kitano S, Ohishi H. Nondiffuse fatty change of the liver: discerning pseudotumor on MR images enhanced with ferumoxides - initial observations. Radiology 2000; 217: 415-420
6. Reimer P, Rummeny EJ, Daldrup HE, Balzer T, Tombach B, Berns T, Peters PE. Clinical results with Resovist®: a phase 2 clinical trial. Radiology 1995; 195: 489-496
7. Kopp AF, Laniado M, Dammann F, Stern W, Grönewäller E, Balzer T, Schimpfky C, Claussen CD. MR imaging of the liver with Resovist®: safety, efficacy, and pharmacodynamic properties. Radiology 1997; 204: 749-756
8. Reimer P, Jahnke N, Fiebich M, Schiema W, Deckers F, Marx C, Holzknecht N, Saini S. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 2000; 217: 152-158
9. Matsuo M, Kanematsu M, Itoh K, Ito K, Maetani Y, Kondo H, Kako N, Matsunaga N, Hoshi H, Shiraishi J. Detection of malignant hepatic tumors: comparison of gadolinium- and ferumoxide-enhanced MR imaging. Am J Roentgenol 2001; 177: 637-643
10. 1-weighted MR imaging. Radiology 1998; 203: 831-836
11. Wang YJ, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001; 11: 2319-2331
12. Hosten N, Kreissig R, Puls R, Amthauer H, Beier J, Rohlfing T, Stroszczynski C, Herbel A, Lemke AJ, Felix R. Fusion von CT- und PET-Daten: Methode und klinische Bedeutung am Beispiel der Planung der laser-induzierten Thermotherapie von Lebermetastasen. Fortschr Röntgenstr 2000; 172: 630-635
13. Uggowitzer MM, Kugler C, Ruppert-Kohlmayr A, Groell R, Raith J, Schreyer H. Aktueller Stand der bildgebenden Diagnostik der fokalen nodulären Hyperplasie der Leber. Fortschr Röntgenstr 2000; 172: 727-738
14. Michel SC, Keller TM, Frohlich JM, Fink D, Caduff R, Seifert B, Marincek B, Kubik-Huch RA. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology 2002; 225: 527-536
15. Krombach GA, Wendland MF, Higgins CB, Saeed M. MR imaging of spatial extent of microvascular injury in reperfused ischemically injured rat myocardium: value of blood pool ultrasmall superparamagnetic particles of iron oxide. Radiology 2002; 225: 479-486
16. Daldrup-Link HE, Rummeny EJ, Ihssen B, Kienast J, Link TM. Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow. Eur Radiol 2002; 12: 1557-1566
17. Hundt W, Petsch R, Helmberger T, Reiser M. Signal changes in liver and spleen after Endorem administration in patients with and without liver cirrhosis. Eur Radiol 2000; 10: 409-416
18. Lim JH, Choi D, Cho SK, Kim SH, Lee WJ, Lim HK, Park CK, Paik SW, Kim YI. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 2001; 220: 669-676
19. Bremer C, Allkemper T, Baermig J, Reimer P. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography. J Magn Reson Imaging 1999; 10: 461-467
20. Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 1999; 210: 459-466
21. Pauleit D, Textor J, Bachmann R, Conrad R, Flacke S, Layer G, Kreft B, Schild H. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Radiology 2002; 222: 73-80
22. Lim JH, Choi D, Cho SK, Kim SH, Lee WJ, Lim HK, Park CK, Paik SW, Kim YI. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 2001; 220: 669-676
23. 1-gewichtete dynamische MRT mit neuen superparamagnetischen Eisenoxidpartikeln (Resovistr): Ergebnisse einer Studie am Phantom sowie an 25 Patienten. Fortschr Röntgenstr 1998; 168: 228-236
24. 1-weighted MR imaging. Radiology 1997; 203: 449-456